https://wsxzaq.shinyapps.io/wsxzaq_nomogram/). The score has been verified among three independent external cohorts (GSE13213, GSE68465 and GSE72094), and is still an independent risk factor for lung adenocarcinoma. In addition, among the other 6 cancers, the OS prognosis of high and low-risk groups of PRS is different (P < 0.05). Our research results have screened multiple platelet differential genes with clinical significance and constructed a meaningful prognostic risk score (PRS)." name="description"> Predicting lung adenocarcinoma prognosis with a novel risk scoring based on platelet-related gene expression - Figure f1 | Aging
Research Paper Volume 13, Issue 6 pp 8706—8719

Predicting lung adenocarcinoma prognosis with a novel risk scoring based on platelet-related gene expression

class="figure-viewer-img"

Figure 1. Differentially expressed platelet receptor-related genes, Gene functional enrichment and identification of hub platelet receptor-related genes. (A) Volcano plot of differentially expressed platelet receptor-related genes (DEPG) in the TCGA. (B) GO enrichment analysis of DEPG. (C) KEGG enrichment analysis of DEPG. (D) Single-factor analysis for DEPG. (E) Diagnosing lung adenocarcinoma patients.